Safety

News

Pfizer's weight-loss aspirations are dealt a heavy blow

Pfizer has been forced to discontinue its oral GLP-1 receptor agonist danuglipron after seeing signs of liver toxicity in late-stage clinical testing.

News

Measles claims another life in US – and RFK Jr lauds vaccine

A second child has died of measles in the midst of an outbreak of cases that has now affected around 642 people in the US since January.

News

Multiple studies of Sarepta's DMD therapy halted after death

Three studies of Sarepta's Elevidys Duchenne gene therapy have been placed on hold as the death of a 16-year-old boy is investigated.

News

Third time not so lucky in J&J's bid to end talc liability

Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming its talc-based products harmed consumers has failed.

News

Sarepta slumps on Elevidys patient death

The death of a patient treated with Sarepta's Duchenne muscular dystrophy gene therapy Elevidys has hit its share price.

News

Lilly uses Oscars ad to warn about 'untested' GLP-1s

Eli Lilly has used an Oscars ad to urge people not to use unapproved and untested weight-loss medicines in a swipe at the compounding sector.

Pfizer's weight-loss aspirations are dealt a heavy blow

Measles claims another life in US – and RFK Jr lauds vaccine

Multiple studies of Sarepta's DMD therapy halted after death

Third time not so lucky in J&J's bid to end talc liability

Sarepta slumps on Elevidys patient death

Lilly uses Oscars ad to warn about 'untested' GLP-1s

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Safety

Editor's Picks